Icure was established in year 2000 by a small team of dedicated scientists to provide R&D services to pharmaceutical firms interested in development and commercialization of novel transdermal drug delivery formulations. Since its inception, ICURE has endeavored to develop novel transdermal application products that are therapeutically effective, convenient to wear and promote high degree of patient compliance. In addition to its in-house R&D activities Icure engages in collaborative research projects with pharmaceutical firms and national research organizations involved in development of new drugs. Icure provides its input by developing by developing custom designed drug delivery systems to meet specific needs the drug compounds and their therapeutic targets.
There is no investment information
No recent news or press coverage available for ICURE Pharm. Inc.
We care about your data, and we'd love to use cookies make your experience better.
